Anthony Mark Masi, M.D.
NPI 1902884844ActiveIndividual· Internal Medicine, Sleep Medicine· Ballwin, MO
Internal Medicine, Sleep Medicine (M.D.) in Ballwin, Missouri, trained at University of Illinois College of Med (Chi/Peor/Rock/Chm-Urb) (class of 1987). Their prescriptions cost Medicare Part D more than their services did: $226,474 for 725 claims, against $33,718 paid for services in 2024. Jazz Pharmaceuticals Inc. was the largest of 7 companies reporting payments in 2025, $389.69 in all, mostly food and beverage.
Overview
| NPI | 1902884844 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Credential | M.D. |
| Sole proprietor | Yes |
| NPI issued | Dec 31, 2005 |
| Last updated in NPPES | Jun 6, 2012 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| Internal Medicine, Sleep Medicine Primary | 207RS0012X | R3P21 | MO |
| Internal Medicine, Pulmonary Disease | 207RP1001X | R3P21 | MO |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Nov 10, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 11, 2026 | No match | — |
| New York OMIG · Nov 11, 2026 | No match | — |
| Ohio Medicaid · Nov 11, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 11, 2026 | No match | — |
| Washington HCA · Nov 11, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Enrolled Practitioner - Sleep Medicine (MO) |
|---|---|
| Accepts assignment | Yes (participating) |
Medicare services in 2024
| Medicare patients | 426 |
|---|---|
| Services billed | 506 across 6 procedure codes |
| Paid by Medicare | $33,718 |
Part D prescriptions in 2024
| Prescriptions (claims) | 725 · 1,058 30-day fills |
|---|---|
| Patients | 135 |
| Total drug cost | $226,474 |
| Generic share | 95% of claims |
Education and affiliations
| Medical school | University of Illinois College of Med (Chi/Peor/Rock/Chm-Urb) |
|---|---|
| Graduation year | 1987 |
| Medicare specialty | Sleep Medicine |
| Secondary specialties | Pulmonary Disease |
Industry payments (Open Payments)
- 2025$389.69 · 15 payments from 7 companies
- 2024$604.17 · 13 payments from 5 companies
Top paying companies in 2025
| Company | Amount | Payments |
|---|---|---|
| Jazz Pharmaceuticals Inc. | $194.36 | 4 |
| Avadel Cns Pharmaceuticals, LLC | $86.98 | 5 |
| Fisher & Paykel Healthcare Inc | $41.36 | 2 |
| Takeda Pharmaceuticals U.S.A., Inc. | $19.96 | 1 |
| Resmed Corp | $18.19 | 1 |
What the 2025 payments were for
- Food and Beverage$239.69 · 14 payments
- Consulting Fee$150.00 · 1 payment
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records